Alvogen, Inc recalls Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: Alvo
Recalled July 14, 2021 · FDA recall D-0649-2021 · Alvogen
Hazard
Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low) · FDA Class II
Units
9,696 cartons
Sold at
USA nationwide.
Description
Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
Product
Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: Alvogen, Inc. Pine Brook, NJ 07058 USA, NDC 47781-355-03
Manufacturer(s)
Alvogen, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →